Table 1: Biofunctionalized crosslinker formulations investigated in the present study.

Distinct Low and High formulations represent varying biomolecule concentration. CS/PdBT was limited to a maximum concentration of 2.6 mM due to the solubility limit of CS as a high molecular weight sGAG.

Crosslinker Formulation	Non-Functionalized PdBT Concentration (mM)	Click-Functionalized PdBT Concentration (mM)
PdBT	25	0
CS/PdBT (Low)	23.7	1.3
CS/PdBT (High)	22.4	2.6
NC/PdBT (Low)	12.5	12.5
NC/PdBT (High)	0	25
BMHP1/PdBT (Low)	12.5	12.5
BMHP1/PdBT (High)	0	25
GHK/PdBT (Low)	12.5	12.5
GHK/PdBT (High)	0	25